title: Triple therapy with non-biologic DMARDs for rheumatoid arthritis or biologic therapy. Is it the same?
authors.affiliation: Unidad Regional de Reumatología y Osteoporosis, Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, S.L.P., México. Electronic address: c_abud@hotmail.com.
authors.forename: Carlos
authors.initials: C
authors.lastname: Abud-Mendoza
authors.affiliation: Unidad Regional de Reumatología y Osteoporosis, Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, S.L.P., México.
authors.forename: Marco U
authors.initials: MU
authors.lastname: Martínez-Martínez
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use*; D007074:Immunoglobulin G / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012460:Sulfasalazine / Q000627:therapeutic use*
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D008727:Methotrexate